Welcome to our dedicated page for Huntington Bancs SEC filings (Ticker: HBANP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Huntington Bancshares Incorporated Depositary Shares 4.500% Series H Non-Cumulative Perpetual (Nasdaq: HBANP) provides direct access to the company’s regulatory disclosures that reference this preferred stock series. In multiple Form 8-K filings, Huntington lists HBANP among the securities registered under Section 12(b) of the Securities Exchange Act of 1934, describing it as depositary shares, each representing a 1/40th interest in a share of 4.500% Series H Non-Cumulative Perpetual Preferred Stock.
Huntington’s 8-K filings also explain how the 4.500% Series H preferred stock ranks within the company’s capital structure. The Series H preferred stock is described as non-cumulative and perpetual, and is identified as ranking on a parity with other specified Huntington preferred stock series with respect to dividends and distributions upon liquidation, while being senior to the company’s common stock and certain other junior securities. These details are set out in charter documents and articles supplementary filed with the State Department of Assessments and Taxation of Maryland and incorporated by reference into SEC filings.
Through this filings page, investors can review 8-Ks that register HBANP on Nasdaq, describe the rights and preferences of Huntington’s preferred stock series, and discuss related capital markets transactions. The filings also reference registration statements and deposit agreements that govern the issuance and administration of depositary shares such as HBANP.
Stock Titan’s interface surfaces these EDGAR filings as they become available and can pair them with AI-powered summaries that highlight key points for HBANP holders, such as how the Series H preferred stock ranks relative to other securities, the nature of its non-cumulative dividend feature, and its perpetual structure. Users can also locate filings that mention other Huntington preferred series, providing additional context for analyzing HBANP within the broader preferred stock framework.
Huntington Bancshares director Richard W. Neu received a quarterly stock award of 3,602.69 shares of common stock on 01/26/2026 under the Directors' Deferred Compensation Plan at a price of $0.0000 per share. Following this award, he indirectly holds 258,018.26 shares through the plan and directly holds 330,434.859 shares of Huntington common stock.
Huntington Bancshares Inc. director Rafael Diaz-Granados reported a routine equity award under the company’s Directors' Deferred Compensation Plan. On January 26, 2026, 3,454.832 shares of common stock were credited at a price of $0.0000 per share, reflecting a quarterly director share award.
After this transaction, 31,610.768 common shares are held indirectly through the Director Deferred Compensation Plan and 35,203.53 common shares are held directly. The filing states that it should not be construed as an admission that the reporting person is the beneficial owner of these securities for Section 16 purposes.
Huntington Bancshares director Ann B. Crane received 2,441.463 shares of common stock as a quarterly award under the Directors' Deferred Compensation Plan. The shares were credited on January 26, 2026 at a stated price of $0.0000 per share, reflecting non-cash compensation.
After this award, Crane held 100,727.054 Huntington shares indirectly through the Director Deferred Compensation Plan and 222,086.136 shares directly. The filing notes that it should not be construed as an admission of beneficial ownership of these securities.
Huntington Bancshares Incorporated reports that its planned merger of Cadence Bank into The Huntington National Bank has cleared key milestones. Shareholders of both Huntington and Cadence approved merger-related proposals, and all required regulatory approvals have been received, so closing is expected on or about February 1, 2026, subject to remaining conditions in the merger agreement.
Huntington also announced an offering of debt securities and, in connection with that offering, is filing Cadence’s audited and interim financial statements and unaudited pro forma combined financial statements for Huntington and Cadence as exhibits. The company notes that these filings do not modify or update Huntington’s previously filed annual or quarterly consolidated financial statements.
Huntington Bancshares Incorporated reported that its Board of Directors declared a quarterly cash dividend on its common stock of $0.155 per share, unchanged from the prior quarter. This dividend will be paid on April 1, 2026, to shareholders who are on record as of March 18, 2026.
The Board also approved quarterly cash dividends on six series of preferred stock. These include per-share dividends of $16.5845 for Floating Rate Series B, $1,406.25 for 5.625% Series F, $1,112.50 for 4.450% Series G, $11.25 for 4.5% Series H, $17.19 for 6.875% Series J, and $1,562.50 for 6.25% Series K. All six preferred dividends are payable on April 15, 2026, to shareholders of record on April 1, 2026.
Huntington Bancshares Incorporated filed a current report describing the public release of its earnings for the quarter ended December 31, 2025. The company issued a news release and a Quarterly Financial Supplement, which are included as Exhibits 99.1 and 99.2 and incorporated by reference.
The filing explains that Huntington’s senior management is hosting an earnings conference call on January 22, 2026 at 9:00 a.m. Eastern Time, with access provided via webcast and dial-in numbers, and replay options available through January 30, 2026. The report also includes an extensive cautionary statement about forward-looking statements, outlining numerous economic, regulatory, operational, and transaction-related risks that could cause actual results to differ from expectations.
Huntington Bancshares Incorporated filed an 8-K announcing the introduction of 6.250% Series K Non-Cumulative Perpetual Preferred Stock and related documents. The filing includes an Underwriting Agreement dated September 9, 2025, Articles Supplementary effective September 10, 2025, a Deposit Agreement dated September 11, 2025, a form of certificate for the Series K shares, a form of depositary receipt for depositary shares, and legal opinions and consents from Venable LLP and Wachtell, Lipton, Rosen & Katz. The Series K shares are pari passu with specified prior parity securities and senior to Huntington common stock and certain junior preferred securities. Redemption of Series K is subject to Federal Reserve approval and holders lack a mandatory redemption right.
Huntington Bancshares insider sale under 10b5-1 plan. Marcy C. Hingst, SEVP and General Counsel, reported an automatic sale of 41,100 shares of Huntington Bancshares common stock on 09/05/2025 pursuant to a Rule 10b5-1 trading plan adopted March 13, 2025. The weighted average sale price was $18, with individual sale prices ranging from $18.00 to $18.01. Following the transaction Hingst beneficially owns 299,361.454 shares. The Form 4 was signed by an attorney-in-fact, Anne Kruger, on 09/09/2025. No options or derivative transactions were reported.
Huntington Bancshares Incorporated filed a current report describing its participation in the 2025 Barclays Global Financial Services Conference on September 8, 2025. Chief Financial Officer Zach Wasserman and President of Consumer and Regional Banking Brant Standridge are scheduled to present to analysts and investors.
The company has provided a copy of the conference presentation slides as Exhibit 99.1, and these slides are also available in the Investor Relations section of its website at www.huntington.com. The slides are being furnished under Regulation FD and are expressly stated as not being "filed" for purposes of the Securities Exchange Act of 1934 and not incorporated by reference into other securities law filings unless specifically referenced.
Huntington Bancshares Incorporated Form 144 notifies the SEC of a proposed sale of 41,100 common shares held for the account of a person associated with the company. The shares were acquired on 11/01/2024 as equity compensation. The filing lists an approximate aggregate market value of $739,820.71 based on the proposed sale and shows 1,458,800,042 shares outstanding for the issuer. The broker named for the sale is Merrill Lynch in New York and the approximate sale date is 09/05/2025 on Nasdaq. The filer also disclosed a prior sale of 13,700 common shares on 06/13/2025 that generated $216,323.00 in gross proceeds. The filer represents there is no undisclosed material information.